Stock Watch:

Explore the Blockchain Technologies ETF, offering exposure to the growing world of fintech, crypto mining, and blockchain advancements.
Bonterra Resources is strengthening its position in the Abitibi gold region through a strategic partnership and key assets, focusing on growth and exploration in this rich mining territory.
Doubleview is exploring massive copper, gold, and scandium resources in British Columbia’s Golden Triangle, positioning itself as a key player in the mining sector.
HomeBTV ShowBTV FeaturesCEO ClipsArticlesInvestor AlertsTV Ad SpotsAnalysts & ExpertsThe Agency

cancer

Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology
Healthcare
Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

May 3, 2023
Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology
Healthcare
Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to deliver treatment drugs to diseased cells.

Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to deliver treatment drugs to diseased cells.

January 2, 2023
BTV Features: Defence Therapeutics, Volatus Aerospace, NGEx Minerals, York Harbour Metals, & AuTECO Minerals
BTV
On national TV Sat. November 12 & Sun. November 13, 2022 – BTV - Business Television showcases emerging companies in the markets.

On national TV Sat. November 12 & Sun. November 13, 2022 – BTV - Business Television showcases emerging companies in the markets.

November 9, 2022
Healthcare
Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response (DDR) technologies.

Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response (DDR) technologies.

May 20, 2022

Latest

HIVE Digital Technologies: ~38,000 Nvidia GPU ChipsCrypto
Centurion Asset Management: Building Strong Portfolios with One Canada’s Largest Private Apartment REITReal Estate
Champion Iron: Revolutionizing Steel with High-Grade Iron OreMetals & Mining

Hot Companies

STLLR Gold
Aston Bay Holdings

Discover Companies to Invest In!

Corp. Videos
Advertising
Broadcast Schedule
The Crew
About us
Contact